Renaissance Technologies
NPCE icon

Renaissance Technologies’s Neuropace NPCE Stock Holding History

Renaissance Technologies’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.29M Sell
174,311
-47,989
-22% -$720K ﹤0.01% 1832
2025
Q4 		$3.43M Buy
222,300
+93,200
+72% +$1.25M 0.01% 1555
2025
Q3 		$1.33M Sell
129,100
-17
-0% -$160 ﹤0.01% 2335
2025
Q2 		$1.44M Sell
129,117
-26,683
-17% -$334K ﹤0.01% 2310
2025
Q1 		$1.91M Buy
155,800
+69,500
+81% +$870K ﹤0.01% 2025
2024
Q4 		$966K Sell
86,300
-700
-0.8% -$6.09K ﹤0.01% 2519
2024
Q3 		$606K Buy
87,000
+5,800
+7% +$42.4K ﹤0.01% 2696
2024
Q2 		$614K Sell
81,200
-38,771
-32% -$391K ﹤0.01% 2601
2024
Q1 		$1.58M Buy
119,971
+11,646
+11% +$166K ﹤0.01% 2179
2023
Q4 		$1.12M Buy
108,325
+64,040
+145% +$511K ﹤0.01% 2335
2023
Q3 		$431K Buy
44,285
+26,985
+156% +$158K ﹤0.01% 2778
2023
Q2 		$78K Buy
17,300
+2,800
+19% +$12.7K ﹤0.01% 3523
2023
Q1 		$67K Buy
14,500
+1,100
+8% +$4.21K ﹤0.01% 3592
2022
Q4 		$20K Buy
13,400
+200
+2% +$444 ﹤0.01% 3966
2022
Q3 		$50K Buy
13,200
+500
+4% +$2.41K ﹤0.01% 3759
2022
Q2 		$63K Buy
+12,700
New +$83.9K ﹤0.01% 3957

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies's NPCE Position: Q1 2026 in Review

Renaissance Technologies reduced its Neuropace (NPCE) stake by 22% in Q1 2026, selling an estimated $720K and leaving 174,311 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1832.

Renaissance Technologies first reported a position in NPCE in Q2 2022 and has held it in 16 quarters since. The position peaked at $3.43M in Q4 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Renaissance Technologies held 174,311 shares of Neuropace worth $2.29M as of Q1 2026.
  • Renaissance Technologies sold 47,989 Neuropace shares in Q1 2026, an estimated $720K.
  • Neuropace made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #1832 holding.
  • Renaissance Technologies first reported a position in Neuropace in Q2 2022 and has held it in 16 quarters since.
  • Renaissance Technologies's Neuropace position peaked at $3.43M in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.